Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

Your logic is correct. This is where Missling has been such a disaster. If Missling had communicated properly and built a real following and interest among external experts, scientific institutions, congresses and patient organizations, as you said, the market cap would be a lot higher (again assuming the technology and data are what the company claims). Remember, roughly half the market cap right now is cash. What’s happened is that Anavex has been a vehicle to feed Missling’s inflated ego. He’s not about building a great company for the benefit of shareholders and patients. He’s about running his own little show where he’s king and everybody works for him. And even worse, the Board has been complicit. Again, look back at Missling’s track record prior to Anavex. He bounced from one job to the next, often lasting no more than a few months in any one job. I’ll surmise that this is a guy who proved to be very difficult to work with. He needed his own show to run as he pleased and he found it in Anavex. And now it’s the shareholders who have paid a steep price. It’s really a shame.